JP2002520269A - 投与剤型 - Google Patents
投与剤型Info
- Publication number
- JP2002520269A JP2002520269A JP2000558798A JP2000558798A JP2002520269A JP 2002520269 A JP2002520269 A JP 2002520269A JP 2000558798 A JP2000558798 A JP 2000558798A JP 2000558798 A JP2000558798 A JP 2000558798A JP 2002520269 A JP2002520269 A JP 2002520269A
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- active ingredient
- dosage
- unit dose
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002552 dosage form Substances 0.000 title claims abstract description 30
- 239000004480 active ingredient Substances 0.000 claims abstract description 26
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims 1
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000000583 progesterone congener Substances 0.000 description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 101150105350 tts1 gene Proteins 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
Abstract
Description
性成分とを同時に投与しうるブリスター型の医薬活性成分の投与剤型に関する。 副作用を防ぐために基礎ホルモンの投与と他のホルモンの投与を組み合わせる
ことは、ホルモン置換療法において一般的である。この方法は、例えば、エスト
ラジオール投与に適用され、ゲスタゲンの投与で行われている。基礎ホルモンの
長期間の連続投与が望まれており、好適な投与剤型として、活性成分リザーバの
所定の接触領域を介して制御されて、皮膚に活性成分が分配される経皮治療シス
テム(TTS)であることが証明されている。このシステムは、感圧接着剤から
なることが好適である。他のホルモンの断続的な随時投薬を望む場合は、投薬は
通常錠剤型で行われる。錠剤は、通常、別々に貯蔵され、少し困難であるが、投
与スケジュールに従って扱われる。そのため、この種の投与剤型は、患者応諾に
は、極めて好ましくない。
及び非経皮経路で医薬活性成分の同時投与に適した包装手法を創生することであ
った。本発明は、適切なデザインの包装により、決められた時間に単位用量の摂
取をするのに、患者を支援することを保障することを意図したものである。
剤型を含むブリスター剤型を新たに見いだしたことによりなされている。TTS
はブリスターに個別に包装されているが、例えば、感圧接着剤接触領域の手段の
ような他の方法で投与剤型に固定することもできる。ブリスターで好都合なこと
は、単位投与量の活性成分剤型、好ましくは錠剤への選択の自由がある方法であ
るか、当然ながら、他の付着機構を考えることも可能である。
ることが証明されている。この方法は、投与プログラムが週ごとに正確にはっき
りと決められている患者に対して意味がある。一連のブリスター剤型は、治療の
理由上必要であれば、単位投与量でない活性成分剤型を有するものを完全に十分
に含めることができる。
ければ、ボーラス状の放出が確保できるように注意する必要がある。他に又は全
身性の活性成分の代わりに、TTS投与領域の局所的予備治療及び事後治療用の
製剤を、単位投与量の活性成分剤型に含めることも可能である。このような製剤
は、例えば、TTSからの活性成分の皮膚浸透性を改善したり、TTSの投与後
の有害な皮膚変化を防止したり、無効にすることさえ可能にする。単位投与量の
活性成分剤型は、TTS遅延時間を補うため、又は24時間周期のリズムで要求
される付加的な血漿ピークを生じさすために、一種以上のTTS活性成分を含ん
でいてもよい。
8で構成された補助単位での新規な投与剤型の応諾を確保する観点を概略したも
のである。参照番号9は、単位投与量の活性成分剤型を示しており、それは1〜
4には含まれていない。
日間及び4日間を交互に)ゲスタゲン投与を行う。
、TTS投与で患者への応諾を不変に改善しうる信頼しうる手段を提供する。
において個々のブリスターにラベルを貼ることにより増すことが可能である。
な投与剤型の応諾を確保する観点を概略したものである。
Claims (7)
- 【請求項1】 少なくとも1つの単位投与量の活性成分剤型と共に経皮治療
システムを含むことを特徴とするブリスター剤型の医薬活性成分用の投与剤型。 - 【請求項2】 数個のブリスター剤型が、応諾を増加させるために互いに結
合されている請求項1による投与剤型。 - 【請求項3】 個々のブリスターが、望まれる一連の使用において、応諾を
増加させるためにラベルが貼られている請求項1による投与剤型。 - 【請求項4】 付加的な単位投与量の活性成分剤型のないブリスター剤型も
存在しうる請求項2又は3による投与剤型。 - 【請求項5】 単位投与量の活性成分剤型が、活性成分の非経皮投与を意図
するものである請求項1〜4の1つ以上による投与剤型。 - 【請求項6】 単位投与量の活性成分剤型が、TTS投与の前及び/又は後
に局所的治療のための製剤を含む請求項1〜5の1つ以上による投与剤型。 - 【請求項7】 単位投与量の活性成分剤型が、TTSを介して投与される1
つ以上の活性成分を含む請求項1〜6の1つ以上による投与剤型。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19831263.6 | 1998-07-11 | ||
DE19831263A DE19831263A1 (de) | 1998-07-11 | 1998-07-11 | Darreichungsform |
PCT/EP1999/004614 WO2000002538A1 (de) | 1998-07-11 | 1999-07-02 | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002520269A true JP2002520269A (ja) | 2002-07-09 |
JP2002520269A5 JP2002520269A5 (ja) | 2005-12-22 |
Family
ID=7873833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000558798A Pending JP2002520269A (ja) | 1998-07-11 | 1999-07-02 | 投与剤型 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6630149B1 (ja) |
EP (1) | EP1096923B1 (ja) |
JP (1) | JP2002520269A (ja) |
KR (1) | KR100529843B1 (ja) |
CN (1) | CN1308529A (ja) |
AT (1) | ATE257377T1 (ja) |
AU (1) | AU4905799A (ja) |
BR (1) | BR9912260A (ja) |
CA (1) | CA2336711C (ja) |
DE (2) | DE19831263A1 (ja) |
DK (1) | DK1096923T3 (ja) |
ES (1) | ES2214869T3 (ja) |
HU (1) | HUP0104941A2 (ja) |
IL (1) | IL140730A0 (ja) |
WO (1) | WO2000002538A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040171992A1 (en) * | 2003-02-28 | 2004-09-02 | Waikiwi Corporation | Cream dispenser providing sequential dispensing means |
DE102006011340A1 (de) * | 2006-03-09 | 2007-09-20 | Grünenthal GmbH | Wirkstoffhaltige Pflaster mit verbesserter Handhabung |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4736849A (en) * | 1983-12-19 | 1988-04-12 | Leonard Walter G | Calendar-oriented pill dispenser |
GB8718797D0 (en) | 1987-08-07 | 1987-09-16 | Ciba Geigy Ag | Container |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
DE3888269T2 (de) * | 1987-09-24 | 1994-07-07 | Jencap Research Ltd | Hormon-Zusammensetzung und -Anwendung. |
US5077104A (en) * | 1989-12-21 | 1991-12-31 | Alza Corporation | Nicotine packaging materials |
DE4223004A1 (de) * | 1992-07-13 | 1994-01-20 | Liedtke Pharmed Gmbh | Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie |
DE19619045C1 (de) * | 1996-05-02 | 1997-11-13 | Jenapharm Gmbh | Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen |
DE29719070U1 (de) * | 1996-10-29 | 1998-05-14 | Byk Gulden Lomberg Chem Fab | Blister für die Kombinationstherapie |
FR2765483B1 (fr) * | 1997-07-04 | 2000-02-04 | Philippe Gorny | Medicament destine a traiter les dysfonctions erectiles |
-
1998
- 1998-07-11 DE DE19831263A patent/DE19831263A1/de not_active Withdrawn
-
1999
- 1999-07-02 WO PCT/EP1999/004614 patent/WO2000002538A1/de active IP Right Grant
- 1999-07-02 AU AU49057/99A patent/AU4905799A/en not_active Abandoned
- 1999-07-02 ES ES99932796T patent/ES2214869T3/es not_active Expired - Lifetime
- 1999-07-02 JP JP2000558798A patent/JP2002520269A/ja active Pending
- 1999-07-02 BR BR9912260-0A patent/BR9912260A/pt not_active Application Discontinuation
- 1999-07-02 AT AT99932796T patent/ATE257377T1/de not_active IP Right Cessation
- 1999-07-02 DE DE59908258T patent/DE59908258D1/de not_active Expired - Fee Related
- 1999-07-02 EP EP99932796A patent/EP1096923B1/de not_active Expired - Lifetime
- 1999-07-02 CN CN99808461A patent/CN1308529A/zh active Pending
- 1999-07-02 CA CA002336711A patent/CA2336711C/en not_active Expired - Fee Related
- 1999-07-02 HU HU0104941A patent/HUP0104941A2/hu unknown
- 1999-07-02 IL IL14073099A patent/IL140730A0/xx unknown
- 1999-07-02 US US09/743,540 patent/US6630149B1/en not_active Expired - Fee Related
- 1999-07-02 KR KR10-2001-7000309A patent/KR100529843B1/ko not_active IP Right Cessation
- 1999-07-02 DK DK99932796T patent/DK1096923T3/da active
Also Published As
Publication number | Publication date |
---|---|
US6630149B1 (en) | 2003-10-07 |
ATE257377T1 (de) | 2004-01-15 |
WO2000002538A1 (de) | 2000-01-20 |
HUP0104941A2 (hu) | 2002-05-29 |
KR100529843B1 (ko) | 2005-11-22 |
BR9912260A (pt) | 2001-10-02 |
ES2214869T3 (es) | 2004-09-16 |
KR20010071795A (ko) | 2001-07-31 |
CA2336711C (en) | 2007-05-29 |
EP1096923A1 (de) | 2001-05-09 |
CA2336711A1 (en) | 2000-01-20 |
DK1096923T3 (da) | 2004-03-29 |
DE59908258D1 (de) | 2004-02-12 |
DE19831263A1 (de) | 2000-01-13 |
CN1308529A (zh) | 2001-08-15 |
IL140730A0 (en) | 2002-02-10 |
EP1096923B1 (de) | 2004-01-07 |
AU4905799A (en) | 2000-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR029159A1 (es) | Preparacion farmaceutica, envase que la contiene y uso en la preparacion de un medicamento util en la terapia de reemplazo hormonal | |
US20070254858A1 (en) | Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects | |
EP1001772A4 (en) | IMPROVEMENTS IN THE ADMINISTRATION OF MULTIPLE DRUG DOSAGES | |
Gupta et al. | Transdermal delivery: product and patent update | |
JP2017036304A (ja) | ブプレノルフィンを含む経皮送達システム | |
Burkman | Transdermal hormonal contraception: benefits and risks | |
PL304860A1 (en) | Drug of prolonged active substance release containing a tramadol salt | |
NO953874L (no) | Farmasöytisk preparat inneholdende lipofile legemidler | |
ATE234602T1 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
CA2294101A1 (en) | A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor | |
JP2002520269A (ja) | 投与剤型 | |
NO320050B1 (no) | Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat. | |
RU2449796C9 (ru) | Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива | |
JP2001513566A5 (ja) | ||
Munoz | OESCLIM®: an advanced delivery system for HRT | |
EP1663247B1 (en) | Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain | |
MXPA01000353A (en) | Blister containing a transdermal therapeutic system and a single dose form of administration | |
Benson et al. | Optimisation of Drug Delivery: 4. Transdermal Drug Delivery | |
US20220110947A1 (en) | Cyproterone acetate compositions and uses thereof | |
JP2002520269A5 (ja) | ||
US20040171992A1 (en) | Cream dispenser providing sequential dispensing means | |
BR0010968A (pt) | Preparação farmacêutica, embalagem farmacêutica, método de tratamento e uso de uma substância estrogenicamente ativa e substância progestogenicamente ativa na preparação de um medicamento | |
BYMIRIAMZIEMAN | Transdermal contraception: update on clinical management | |
Liu et al. | Advances in transdermal estrogen-only therapy for vasomotor symptoms | |
Bélanger | Product Update |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040921 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040921 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080603 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080821 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090227 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091201 |